NEW YORK, Jan. 07, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of The Allstate Corporation securities (NYSE:ALL) from October 30, 2014 through August 3, 2015, both dates inclusive (the “Class Period”) of the important January 9, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Allstate investors under the federal securities laws.
To join the Allstate class action, go to http://www.rosenlegal.com/cases-993.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that the reason for the sudden spike in its auto claims frequency, which defendants claimed was due to external events beyond the Allstate’s control, was actually the result of Allstate’s growth in its auto policy business through higher risk drivers. On August 3, 2015, Allstate reported disappointing second quarter 2015 financial results, including a third consecutive quarter of increased auto claims frequency, a 57% decline in operating income, and operating earnings per share that were $0.34 below analysts’ consensus estimate. On that same day, Allstate’s CEO stated that the lower quarterly profit was “driven by a deterioration in auto insurance margins” and explained that “[a]uto insurance margins decreased as higher claim frequency and severity more than offset average auto insurance price increases.” On this news, shares of Allstate fell $7.04 per share to close at $62.34 per share on August 4, 2015.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 9, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-993.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected]. Attorney Advertising. Prior results do not guarantee a similar outcome.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 



